RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $327,443 | -78.9% | 253,832 | -78.1% | 0.04% | -79.4% |
| Q1 2023 | $1,551,175 | -15.6% | 1,157,593 | -5.5% | 0.17% | -11.5% |
| Q4 2022 | $1,837,622 | +105.8% | 1,225,081 | 0.0% | 0.19% | +104.3% |
| Q3 2022 | $893,000 | -35.5% | 1,225,081 | 0.0% | 0.09% | -40.1% |
| Q2 2022 | $1,384,000 | -63.8% | 1,225,081 | -4.1% | 0.16% | -58.4% |
| Q1 2022 | $3,821,000 | -6.2% | 1,277,770 | -15.9% | 0.38% | +39.1% |
| Q4 2021 | $4,074,000 | -26.2% | 1,520,000 | 0.0% | 0.27% | -30.0% |
| Q3 2021 | $5,518,000 | -16.4% | 1,520,000 | 0.0% | 0.39% | -13.6% |
| Q2 2021 | $6,597,000 | +26.9% | 1,520,000 | 0.0% | 0.45% | +23.8% |
| Q1 2021 | $5,198,000 | -14.5% | 1,520,000 | -12.5% | 0.36% | -27.0% |
| Q4 2020 | $6,077,000 | +45.8% | 1,736,176 | 0.0% | 0.50% | +33.7% |
| Q3 2020 | $4,167,000 | +31.2% | 1,736,176 | 0.0% | 0.37% | +8.2% |
| Q2 2020 | $3,177,000 | +17.3% | 1,736,176 | 0.0% | 0.34% | -9.5% |
| Q1 2020 | $2,708,000 | -33.4% | 1,736,176 | -8.6% | 0.38% | -15.0% |
| Q4 2019 | $4,066,000 | +8.7% | 1,900,000 | -5.0% | 0.45% | -4.9% |
| Q3 2019 | $3,740,000 | -36.7% | 2,000,000 | -11.7% | 0.47% | -28.0% |
| Q2 2019 | $5,911,000 | +1.5% | 2,264,942 | 0.0% | 0.65% | -4.4% |
| Q1 2019 | $5,821,000 | +11.7% | 2,264,942 | 0.0% | 0.68% | +14.5% |
| Q4 2018 | $5,209,000 | -23.2% | 2,264,942 | +7.1% | 0.60% | -12.5% |
| Q3 2018 | $6,786,000 | +40.8% | 2,113,988 | +24.1% | 0.68% | +37.9% |
| Q2 2018 | $4,820,000 | -15.8% | 1,703,278 | +5.3% | 0.49% | -30.2% |
| Q1 2018 | $5,727,000 | -23.6% | 1,617,769 | -16.3% | 0.71% | -30.3% |
| Q4 2017 | $7,499,000 | +25.6% | 1,932,831 | -17.8% | 1.01% | +32.9% |
| Q3 2017 | $5,969,000 | +58.9% | 2,350,000 | +70.8% | 0.76% | +41.4% |
| Q2 2017 | $3,756,000 | -11.5% | 1,375,900 | +7.3% | 0.54% | -19.8% |
| Q1 2017 | $4,243,000 | +39.1% | 1,282,000 | 0.0% | 0.67% | +14.9% |
| Q4 2016 | $3,051,000 | -99.9% | 1,282,000 | -8.4% | 0.58% | -28.3% |
| Q3 2016 | $5,138,000,000 | +270891.6% | 1,400,000 | +64.7% | 0.82% | +142.1% |
| Q2 2016 | $1,896,000 | +7.2% | 850,000 | 0.0% | 0.34% | -4.0% |
| Q1 2016 | $1,768,000 | -30.9% | 850,000 | +0.7% | 0.35% | -9.3% |
| Q4 2015 | $2,558,000 | +11.9% | 844,313 | -8.7% | 0.39% | +6.3% |
| Q3 2015 | $2,285,000 | -23.0% | 925,000 | 0.0% | 0.36% | +2.0% |
| Q2 2015 | $2,969,000 | -16.8% | 925,000 | -7.5% | 0.36% | -40.7% |
| Q1 2015 | $3,570,000 | – | 1,000,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |